Chronic Transcranial Direct Current Stimulation in Patients With Systemic

Status Recruiting

Clinical Trial Summary

Systemic autoimmune myopathies are rheumatic diseases that affect the striatum skeletal muscles. The transcranial direct current stimulation technique has been frequent, for example, in patients with ischemic stroke or for the optimization of muscular performance in athletes. However, to date, there are no studies evaluating this technique in patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, double-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of chronic transcranial direct current stimulation sessions - associated with aerobic exercises - in the patients with systemic autoimmune myopathies.

Clinical Trial Description

Systemic autoimmune myopathies are rheumatic diseases that affect the striatum skeletal muscles. Depending on the clinical, pathophysiological and laboratory characteristics, they may be subdivided into polymyositis, dermatomyositis, antissintetase syndrome, immune-mediated necrotizing myopathy, and among others. Recently, the literature has been presenting better pharmacological treatment options to control these diseases. Despite these advances, this group of diseases still continues to be associated with high morbidity and functional disability, mainly due to the proximal muscular weakness of the scapular and pelvic girdles that may prevent the total recovery of these patients. On the other hand, the association of the transcranial current stimulation technique with motor recovery has been frequent, for example, in patients with ischemic stroke or for the optimization of muscular performance in athletes. However, to date, there are no studies evaluating this technique in patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, double-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of chronic transcranial current stimulation session - associated with aerobic exercises - in patients with systemic autoimmune myopathies. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04678635
Study type	Interventional
Source	University of Sao Paulo
Contact	Samuel K Shinjo, PhD
Phone	55113061-7176
Email	samuel.shinjo@usp.br
Status	Recruiting
Phase	N/A
Start date	December 12, 2020
Completion date	May 16, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06374719` - WiTNNess - TNNT1 Myopathy Natural History Study
Not yet recruiting	`NCT03633565` - Comparative Study of Strategies for Management of Duchenne Myopathy (DM)	Phase 4
Enrolling by invitation	`NCT02235220` - Reduction of Masticatory Muscle Activity by Restoring Canine Guidance	N/A
Terminated	`NCT00278564` - Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases	Phase 1
Completed	`NCT01642056` - EPI-743 for Metabolism or Mitochondrial Disorders	Phase 1/Phase 2
Completed	`NCT02011282` - Electro-Neuro-Muscular Stimulation in ICU	N/A
Completed	`NCT01702987` - Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS	N/A
Active, not recruiting	`NCT01225614` - Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive	Phase 3
Recruiting	`NCT03749538` - Acute Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies	N/A
Completed	`NCT02442986` - Neurological Outcome in Surgical and Non-surgical Septic Patients	N/A
Recruiting	`NCT01022450` - Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients	N/A
Withdrawn	`NCT00990834` - Muscle Characteristics Associated With Statin Therapy	N/A
Active, not recruiting	`NCT00937001` - Critical Illness Myopathy as a Cause of Debilitating ICU-Acquired Weakness	N/A
Recruiting	`NCT01353430` - Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)
Completed	`NCT03751644` - Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies	N/A
Completed	`NCT02765828` - Identification of Tongue Involvement in Late-Onset Pompe Disease
Recruiting	`NCT05599568` - Repeated Bout Effect i Neuromuscular Diseases	N/A
Withdrawn	`NCT02124070` - Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis	Phase 1/Phase 2
Completed	`NCT02706314` - Impact of Human Blood Serum From Critically Ill Patients on Human Colon Neuronal Networks.
Recruiting	`NCT03042286` - SAPhIRE Statin Adverse Drug Reaction

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms